Seed and pre-Series A fund research profile
Axilor Ventures is a Bengaluru-based seed manager backing technology companies before the market has fully formed around them. The platform combines an enterprise and deep-tech seed thesis with a climate vehicle, giving allocator-side users a more useful view than treating all Axilor activity as one undifferentiated fund.
At a glance
Research profile
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
Axilor Ventures uses a seed and pre-series a; technology venture capital approach across Enterprise SaaS, deep tech, healthcare, climate.
Current evidence
Axilor’s official 2023 research and portfolio archive continues to document its seed mandate, while its current website maintains AIF registrations and active portfolio companies including CapGrid, SwitchOn and Medfin.
Strategy
Seed and pre-Series A; technology venture capital
Sector focus
Enterprise SaaS, deep tech, healthcare, climate
AIF structure context
Indian venture capital and angel-fund strategies are commonly structured as Category I AIFs. Verify the specific vehicle and registration before investing.
Current signal
Axilor’s official 2023 research and portfolio archive continues to document its seed mandate, while its current website maintains AIF registrations and active portfolio companies including CapGrid, SwitchOn and Medfin.
Investor questions
Axilor Ventures is covered in Rupeia's venture capital research universe. The current public record describes the strategy as Seed and pre-Series A; technology venture capital, with a sector focus of Enterprise SaaS, deep tech, healthcare, climate. The profile should be read with the linked source trail and Typical route: Category I AIF context.
The profile displays only company or asset names attributable to Axilor Ventures in the reviewed public sources: CapGrid, SwitchOn, Medfin, FreshR, Pepper Farms, Algorithmic Biologics, Fleek, Wiz, iCanPe, Detect Technologies, Cancer Clinics, Advantage Club, Metalbook, Alyve Health, Moonrider. It does not represent a complete current portfolio unless the manager has published one.
Axilor announced its second technology fund at $100 million and continues to identify active technology and climate positions through its official site. Public sources attribute CapGrid, SwitchOn, Medfin, FreshR, Pepper Farms, Algorithmic Biologics, Wiz and Detect Technologies to the platform; fund-level audited returns are not publicly disclosed. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.
Public fund size: $100 million Axilor Technology Fund II announced in 2022; current combined AUM and uncalled capital are not publicly disclosed.. Public terms or access information: Seed and pre-Series A investing with follow-on support; public reporting describes first cheques up to approximately $1.5 million and follow-ons up to $2–3 million, while complete fee and carry terms are not disclosed.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.
The current source record names Ganapathy Venugopal (Co-founder); Srinath Batni (Co-founder); Prachi Sinha (Investment lead). Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.
Review stage concentration, follow-on reserves, company failure rates, dilution, exit timing and the gap between paper valuations and realised distributions. The current open diligence point is: Vehicle-level current AUM, audited returns, ownership percentages and complete fee/carry terms are not publicly disclosed. Axilor Technology Fund I, Axilor Technology Fund II and Micelio Technology Fund I are bundled into one manager record..
2023-05-15: Axilor’s official 2023 research and portfolio archive continues to document its seed mandate, while its current website maintains AIF registrations and active portfolio companies including CapGrid, SwitchOn and Medfin.
Next step
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.